English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia
Apr 19, 2021 09:00 HKT
Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans
Apr 07, 2021 15:00 HKT
Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021
Apr 06, 2021 13:29 HKT
Viva Biotech Announced 2020 Annual Results
Mar 31, 2021 07:05 HKT
TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020
Mar 24, 2021 07:35 HKT
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan
Mar 24, 2021 05:00 HKT
Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity
Mar 23, 2021 17:09 HKT
Ocumension Therapeutics (1477.HK) Announces 2020 Annual Results
Mar 20, 2021 10:10 HKT
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission
Mar 19, 2021 14:34 HKT
Alvotech Completes Second Round of a US$100 Million Private Placement
Mar 15, 2021 17:38 HKT
Size matters: Bimodal imaging receives nanoparticle enhancement
Mar 10, 2021 20:00 HKT
Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer
Mar 09, 2021 10:35 HKT
APOLLOMICS, INC ANNOUNCES SUCCESSFUL ENROLLMENT OF FIRST PATIENT INTO PHASE 1 CLINICAL TRIAL OF APL-106 (UPROLESELAN INJECTION) IN CHINA
Mar 04, 2021 11:30 HKT
Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand
Mar 04, 2021 10:26 HKT
Maculus Therapeutix welcomes Privity, Prepares Capital Raise for Novel Drug Delivery Platform
Feb 19, 2021 07:00 HKT
Suntrap Discovered 'LeSoleil' for COVID-19 and the Epidemic
Feb 14, 2021 20:00 HKT
Cofttek, China's Largest Manufacturer of PEA, Draws Attention of Investors
Feb 14, 2021 01:00 HKT
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
Feb 12, 2021 13:00 HKT
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Feb 11, 2021 21:00 HKT
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
Feb 11, 2021 11:00 HKT
Next >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: